SEC Form 4 · accession 0001445064-15-000035
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Meredith B Fischer
Officer — Sr. VP, Comm & Public Affairs
Period of report
Mar 1, 2015
Accepted (ET)
Mar 3, 2015 · 6:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Mar 1, 2015 | F | 764 | $116.72 | D | 11,856 | D |
Table II — derivative securities
No Table II lines on this filing.